Interest in long-acting injectable buprenorphine among syringe services program participants
Journal of Opioid Management · 01.08.2021 · 17 (7) · 59-67
DOI: 10.5055/jom.2021.0643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Opioid Management, online erschienen am 01.08.2021. Verfasst von Hannah Epstein und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of General Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New Yor…. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Objective
To examine syringe services program (SSP) participants’ interest in long-acting injectable buprenorphine.
Design
SSP participants completed a 136-item questionnaire by phone. Items assessed quantitative ratings of interest in sublingual and injectable buprenorphine, preference for sublingual versus injectable buprenorphine, and reasons for preferences.
Setting
Two large urban SSPs.
Participants
SSP participants ≥18 years of age with current or lifetime opioid use disorder (OUD).Main outcome measure(s): (1) Interest in sublingual and injectable buprenorphine, respectively, on a scale from 0 to 10 (0 = no interest and 10 = high interest); and (2) preference for sublingual buprenorphine versus injectable buprenorphine. Participants were also asked whether they agreed with statements that presented potential reasons for preferring each formulation.
Results
A total of 104 unique participants were interviewed, of which 72 (69 percent) were currently receiving or considering buprenorphine treatment. Among these 72 participants, the median level of interest in starting or continuing sublingual buprenorphine was 8 out of 10 (interquartile range [IQR]: 6-10) and in starting injectable buprenorphine was 5 out of 10 (IQR: 1-9). Thirty-six (50 percent) preferred sublingual, 27 (38 percent) preferred injectable, and 9 (13 percent) preferred neither or declined to answer. Participants who preferred injectable buprenorphine most commonly agreed that the convenience of the monthly injection was the reason for their preference.
Conclusions
Among SSP participants with OUD, we found moderate interest in injectable buprenorphine. Introducing this new form of buprenorphine treatment at SSPs could help meet the needs of individuals who are not well-served by standard OUD treatment models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of General Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
- Washington Heights Corner Project, New York, New York.
- New York Harm Reduction Educators, New York, New York.
- New York Harm Reduction Educators, Washington Heights Corner Project, New York, New York.
- Department of Internal Medicine, Division of General Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York. ORCID: https://orcid.org/0000-0001-5651-5589.
Zitieren
APA
Epstein, H., Perez-Correa, A., Beltre, J., Fitzsimmons, C., Marcus, P., Ramirez, F., Stern, L. S., Norton, B. L., Fox, A. D., & Jakubowski, A. (2021). Interest in long-acting injectable buprenorphine among syringe services program participants. Journal of Opioid Management, 17(7), 59-67. https://doi.org/10.5055/jom.2021.0643
Vancouver
Epstein H, Perez-Correa A, Beltre J, Fitzsimmons C, Marcus P, Ramirez F, et al. Interest in long-acting injectable buprenorphine among syringe services program participants. Journal of Opioid Management. 2021;17(7):59-67. doi:10.5055/jom.2021.0643
BibTeX
@article{Epstein2021,
author = {Epstein, Hannah and Perez-Correa, Andres and Beltre, Jason and Fitzsimmons, Christine and Marcus, Pia and Ramirez, Franklin and Stern, L Synn and Norton, Brianna L and Fox, Aaron D and Jakubowski, Andrea},
title = {Interest in long-acting injectable buprenorphine among syringe services program participants},
journal = {Journal of Opioid Management},
year = {2021},
volume = {17},
number = {7},
pages = {59--67},
doi = {10.5055/jom.2021.0643}
}
EUVIMED